A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
This study is currently recruiting participants.
Verified September 2017 by Genentech, Inc.
First Posted: October 29, 2008
Last Update Posted: September 13, 2017
Information provided by (Responsible Party):